Ratio Wealth Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$358K Sell
2,260
-42
-2% -$6.68K 0.07% 64
2023
Q4
$361K Buy
2,302
+41
+2% +$6.29K 0.08% 61
2023
Q3
$352K Buy
2,261
+185
+9% +$30.5K 0.09% 58
2023
Q2
$344K Buy
+2,076
New +$335K 0.09% 53
2022
Q4
$288K Sell
1,632
-43
-3% -$7.42K 0.08% 49
2022
Q3
$274K Sell
1,675
-237
-12% -$40.1K 0.09% 50
2022
Q2
$339K Buy
1,912
+2
+0.1% +$356 0.11% 44
2022
Q1
$339K Sell
1,910
-8
-0.4% -$1.36K 0.1% 45
2021
Q4
$328K Sell
1,918
-86
-4% -$14.1K 0.1% 42
2021
Q3
$324K Hold
2,004
0.11% 43
2021
Q2
$330K Buy
2,004
+42
+2% +$6.95K 0.12% 39
2021
Q1
$323K Buy
1,962
+23
+1% +$3.72K 0.13% 38
2020
Q4
$305K Buy
+1,939
New +$286K 0.16% 38

Other funds holding JNJ

Ratio Wealth Group's JNJ Position: Q1 2024 in Review

Ratio Wealth Group reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2024, selling an estimated $6.68K and leaving 2,260 shares worth $358K. The position accounts for 0.07% of the portfolio, ranked #64.

Ratio Wealth Group first reported a position in JNJ in Q4 2020 and has held it in 13 quarters since. The position peaked at $361K in Q4 2023. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Ratio Wealth Group held 2,260 shares of Johnson & Johnson worth $358K as of Q1 2024.
  • Ratio Wealth Group sold 42 Johnson & Johnson shares in Q1 2024, an estimated $6.68K.
  • Johnson & Johnson made up 0.07% of Ratio Wealth Group's portfolio in Q1 2024, its #64 holding.
  • Ratio Wealth Group first reported a position in Johnson & Johnson in Q4 2020 and has held it in 13 quarters since.
  • Ratio Wealth Group's Johnson & Johnson position peaked at $361K in Q4 2023.
  • 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Ratio Wealth Group's 13F filing for Q1 2024, filed 13 May 2024.